Safety of the long-time monthly triple dose of a Gd-based contrast agent

Francesco Sardanelli; Gianluigi Mancardi; Massimo Filippi

doi:10.1007/s00330-003-1830-y

Related publications

Article1997

A multicentre longitudinal study comparing the sensitivity of monthly enhanced MRI after single and triple dose gd-DTPA injection for monitoring disease activity in multiple sclerosis

Massimo Filippi, M. Rovans, Maria Pia Sormani, Claudio Gasperini, Ruggero Capra, Tarek Yousry, Vittorio Martinelli, Stefano Bastianello, F. Prandini, I Kühne, Gıancarlo Comı

Article1997

2-31-15 A multicentre longitudinal study comparing the sensitivity of monthly enhanced MRI after single and triple dose Gd-DTPA injection for monitoring disease activity in multiple sclerosis

Massimo Filippi, Marco Rovaris, Maria Pia Sormani, Claudio Gasperini, Ruggero Capra, Maria A. Rocca, Stefano Bastianello, F. Prandini, Giancarlo Comi

Article2000

A comparison of the sensitivity of MRI after double- and triple-dose Gd-DTPA for detecting enhancing lesions in multiple sclerosis☆

Claudio Gasperini, Andrea Paolillo, Marco Rovaris, Tarek Yousry, Ruggero Capra, Stefano Bastianello, Massimo Filippi

Article1999

Cumulative effect of a weekly low dose of interferon beta 1a on standard and triple dose contrast-enhanced MRI from multiple sclerosis patients

Marco Rovaris, Ruggero Capra, Vittorio Martinelli, Claudio Gasperini, F. Prandini, Carlo Pozzilli, Giancarlo Comi, Massimo Filippi

Article1999

Correlation between MRI and Short-Term Clinical Activity in Multiple Sclerosis: Comparison between Standard- and Triple-Dose Gd-Enhanced MRI

Marco Rovaris, M. Rodegher, Giancarlo Comi, Massimo Filippi